Multiple myeloma Leu167Ile (c.499C>A) mutation prevents XBP1 mRNA splicing
Authors:
Open Access
- 5 April 2013
- journal article
- other
- Published by Wiley in British Journal of Haematology
- Vol. 161 (6) , 898-901
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myelomaBiochemical and Biophysical Research Communications, 2012
- IRE1/bZIP60-Mediated Unfolded Protein Response Plays Distinct Roles in Plant Immunity and Abiotic Stress ResponsesPLOS ONE, 2012
- Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1Haematologica, 2011
- Conserved RNA structures in the non-canonical Hac1/Xbp1 intronRNA Biology, 2011
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatmentsBlood, 2010
- The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma PathogenesisCancer Cell, 2007
- Rapid Turnover of Unspliced Xbp-1 as a Factor That Modulates the Unfolded Protein ResponseJournal of Biological Chemistry, 2006
- Role of the unfolded protein response in cell deathApoptosis, 2006
- A Novel Mechanism for Regulating Activity of a Transcription Factor That Controls the Unfolded Protein ResponseCell, 1996